FDA Inspection
Gemini Pharmaceuticals, Inc.Gemini Pharmaceuticals, Inc. – FDA Inspection, Sep 7, 2012
Record Details
This FDA Inspection record concerns Gemini Pharmaceuticals, Inc., with an inspection on September 7, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Gemini Pharmaceuticals, Inc.
- Inspection Date
- September 7, 2012
- Product Type
- Drugs
View Company Profile
ID · 8ccd38c4-b04f-4a2f-a1ab-040379671397
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 804876
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Gemini Pharmaceuticals, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2026 | VAI | New York District Office | Food Composition, Standards, Labeling and Econ |
| July 26, 2022 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| August 23, 2018 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| February 16, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 30, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gemini Pharmaceuticals, Inc.
- FDA Inspection 1317530 - 2026-05-15
- FDA Inspection 1175407 - 2022-07-26
- FDA Inspection 1064447 - 2018-08-23
- FDA Inspection 1041525 - 2018-02-16
- FDA Inspection 936886 - 2015-06-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.